Immunotherapy using T cell defined tumor antigens for melanoma

被引:10
作者
Kawakami, Y [1 ]
机构
[1] Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res,Shinjuku Ku, Tokyo 1608582, Japan
关键词
tumor antigens; melanosomal proteins; peptides; dendritic cells; immunotherapy;
D O I
10.1111/j.1348-0421.1998.tb02355.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
引用
收藏
页码:803 / 813
页数:11
相关论文
共 62 条
[1]
Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity [J].
Blachere, NE ;
Li, ZH ;
Chandawarkar, RY ;
Suto, R ;
Jaikaria, NS ;
Basu, S ;
Udono, H ;
Srivastava, PK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) :1315-1322
[2]
THE TYROSINASE GENE CODES FOR AN ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS [J].
BRICHARD, V ;
VANPEL, A ;
WOLFEL, T ;
WOLFEL, C ;
DEPLAEN, E ;
LETHE, B ;
COULIE, P ;
BOON, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :489-495
[3]
A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes [J].
Brichard, VG ;
Herman, J ;
VanPel, A ;
Wildmann, C ;
Gaugler, B ;
Wolfel, T ;
Boon, T ;
Lethe, B .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :224-230
[4]
Cormier JN, 1998, INT J CANCER, V75, P517, DOI 10.1002/(SICI)1097-0215(19980209)75:4<517::AID-IJC5>3.0.CO
[5]
2-W
[6]
Cormier JN, 1997, CANCER J, V3, P37
[7]
A MUTATED INTRON SEQUENCE CODES FOR AN ANTIGENIC PEPTIDE RECOGNIZED BY CYTOLYTIC T-LYMPHOCYTES ON A HUMAN-MELANOMA [J].
COULIE, PG ;
LEHMANN, F ;
LETHE, B ;
HERMAN, J ;
LURQUIN, C ;
ANDRAWISS, M ;
BOON, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7976-7980
[8]
IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES [J].
COX, AL ;
SKIPPER, J ;
CHEN, Y ;
HENDERSON, RA ;
DARROW, TL ;
SHABANOWITZ, J ;
ENGELHARD, VH ;
HUNT, DF ;
SLINGLUFF, CL .
SCIENCE, 1994, 264 (5159) :716-719
[9]
Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape [J].
Hahne, M ;
Rimoldi, D ;
Schroter, M ;
Romero, P ;
Schreier, M ;
French, LE ;
Schneider, P ;
Bornand, T ;
Fontana, A ;
Lienard, D ;
Cerottini, JC ;
Tschopp, J .
SCIENCE, 1996, 274 (5291) :1363-1366
[10]
Irvine KR, 1996, J IMMUNOL, V156, P238